Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas
- 7 August 2009
- journal article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 3 (4), 537-543
- https://doi.org/10.1007/s12072-009-9146-x
Abstract
The proportion of B-HCC cases in Taiwan has progressively decreased over the last 20 years. It was not really due to an overall decrease in B-HCC but due to an increase in HCV-related HCC. The identification of potential HCV endemic areas in Taiwan has consequently become important. Data were collected retrospectively from eight Taiwan medical centers from 1981 to 2001, the geographical variations of male C-HCC townships in Taiwan were illustrated on maps. Goodness of fit was used to compare the anti-HCV prevalence in townships and cities, with the mean anti-HCV prevalence for Taiwan as a whole. Township-, city-, and county-specific prevalence of anti-HCV was presented as the median, ranges, and SMRs. Geographic variation can be analyzed in only 263 townships and cities. The maps were designed on the basis of different SMRs. The mean anti-HCV prevalence for male HCC patients in Taiwan was 31.9% (95% confidence interval: 30.7–33.0). Twenty-five townships distributed throughout central-western and south-western Taiwan have significantly higher prevalence (P < 0.05) (12 townships SMR ≥ 2; 13 townships 1.5 ≤ SMR < 2). Twenty-two townships have significantly lower prevalence (P < 0.05) (6 townships 0.5 ≤ SMR<1; 16 townships SMR < 0.5). Four different patterns of geographic variation in different counties were also noted and demonstrated. We successfully highlighted some potential high HCV endemic townships in Taiwan.Keywords
This publication has 19 references indexed in Scilit:
- Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening ParticipantsJournal of the Formosan Medical Association, 2007
- Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic reviewBritish Journal of Cancer, 2007
- Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV‐endemic areas in an HBV‐endemic country: Geographic variations among 502 villages in southern TaiwanJournal of Gastroenterology and Hepatology, 2006
- A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in TaiwanAntiviral Therapy, 2006
- Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: Long-term trends in JapanOncology Reports, 2006
- Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in TaiwanInternational Journal of Cancer, 2006
- Effects of Adding Ribavirin to Interferon to Treat Chronic Hepatitis C InfectionArchives of Internal Medicine, 2005
- Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factorsJournal of Medical Virology, 2001
- Rising Incidence of Hepatocellular Carcinoma in the United StatesThe New England Journal of Medicine, 1999
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenThe New England Journal of Medicine, 1997